- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13.03. | Mallinckrodt, Endo to combine in $7B deal | ||
| 12.03. | Roche broadens obesity drug plans with $1.65B Zealand Pharma deal | ||
| 12.03. | A new obesity biotech launches; Gilead plans to quickly advance once-yearly PrEP for HIV | ||
| 12.03. | Flagship startup raises $200M in pursuit of 'scientific superintelligence' | ||
| 12.03. | Ono pays $280M to license Ionis rare disease drug | ||
| 11.03. | Douglas Kelly, deputy science director at FDA's device center, leaves agency | ||
| 11.03. | Viking inks CordenPharma deal to boost obesity drug supply | ||
| 11.03. | Merck opens $1B vaccine plant in North Carolina | ||
| 11.03. | Arvinas gets positive breast cancer data, but finds differentiation a hard sell | ||
| 11.03. | 2seventy bio, Bluebird's cell therapy spinout, sells to Bristol Myers for less than $300M | ||
| 10.03. | Beam base editing therapy gets 'proof of concept' in rare lung disease | ||
| 10.03. | Novo's Wegovy successor disappoints in second large trial | ||
| 10.03. | Mineralys shares climb on study data for blood pressure drug | ||
| 10.03. | SynWeave: Revolutionizing biopharma manufacturing by improving titer, timelines and manufacturability | ||
| 10.03. | 3 ways to accelerate development and de-risk cell and gene therapy manufacturing | ||
| 07.03. | J&J scraps depression testing for potential blockbuster drug | ||
| 07.03. | Walgreens to be acquired in $10B take-private deal | ||
| 07.03. | Roche launches new Boston center; NIH centralizes peer review | ||
| 07.03. | Nimbus swaps CEOs and turns to new leader for 'next chapter' | ||
| 07.03. | Vertex's new pain drug gets first coverage nod from major insurer | ||
| 06.03. | Following FDA cuts, Trump nominee Makary vows 'independent' staff review | ||
| 06.03. | Makary, under review to run FDA, evades pressure to reinstate canceled vaccine meeting | ||
| 06.03. | Federal judge extends block on Trump plan to limit NIH payouts | ||
| 06.03. | The top 3 impacts of Trump's health data purge | ||
| 06.03. | Amgen readies pivotal MariTide trials; Novo offers discounted Wegovy |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
